73 results
Page 3 of 4
6-K
EX-99.1
939qw l2korjy
4 Jun 20
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
6:11am
6-K
bk2 9hxds
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.2
0kd3mw luui0
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
wj1zq mt0
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.3
9emujf ejergxm
7 Nov 19
Current report (foreign)
9:11am
F-3
edwi8y4byjezt7ptq6o
7 Aug 19
Shelf registration (foreign)
8:24am
424B5
xl4zeqeeejy0jf 8z
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
ig5nmm6 1ww1vay6h
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.2
hhz6i
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.3
kuy5 gdqe1qbb3
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
EX-99.2
q810yb td
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
EX-99.3
cdixw0 jdp9
8 Aug 18
Index to Unaudited Consolidated Interim Financial Statements
7:00am
6-K
yntus764qyud1tugh9
25 Jul 18
Current report (foreign)
8:21am
6-K
EX-1.1
rs3jnwg8 e7p0
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
424B5
89ms7wtj whkesu1
20 Jun 18
Prospectus supplement for primary offering
5:32pm
424B5
m1il l8z4kkay19fb9r
18 Jun 18
Prospectus supplement for primary offering
9:15pm